USPTO serial 79319475
GENEENGINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 13, 2023
- Examiner
- COUGHLAN, REBECCA D.
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GENEENGINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ROBERT A. BECKER
Robert A. Becker Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th Fl.New York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific, research, and production electronic apparatus and electronic instruments for the development of pharmaceutical preparations; electronic devices, namely, electroporators featuring combinations of fluid motion, and mixture, and measure devices, and cellular compatible plastic tubings, and containers for transferring molecules, all for research and analysis purposes; and electronic devices, namely, electroporators for detecting, selecting and sorting cells in which molecules are transferred, all for research and analysis purposes; pulse generators for electroporation, all for research and analysis purposes, and electric fields of the type used in electroporation, namely, electroporators, for transferring chemical or biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins or nucleic acids, all for research and analysis purposes; apparatus and instruments designed for electroporation for research and analysis purposes; electroporation apparatus and peripheral equipment relating thereto, namely, electroporators and electroporation chambers in the nature of cuvettes for research and analysis purposes; apparatus and instruments for conducting, switching, transforming, accumulating, controlling and monitoring electricity, through electric capacitors, transistors, power semiconductors, relays, transformers, electric contacts and conductors, electric control and measuring instruments; reaction devices, containers and vessels, namely, cell compatible plastic tubings and electroporation chambers for biochemical use for laboratories and other than for medical use, in particular for transferring chemical or biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and transient production of proteins or nucleic acids; test tubes; metal electrodes not for medical use; vessels of synthetic materials for laboratory use and other than for medical purposes in the nature of electroporators composed of cell compatible plastics or cell compatible metal or conductive polymer electrodes as well as electroporation chambers; vessels, namely, electroporation chambers in the nature of cuvettes featuring electrodes of metal and conductive polymers, for biochemical use and for laboratory use and other than for medical use; containers and reaction vessels having several reaction chambers, namely, electroporation chambers in the nature of cuvettes featuring electrodes of metal and conductive polymers, for biochemical use and for laboratory use and other than for medical use; multi-well plates featuring electrodes of metal and conductive polymers, for biochemical analysis for laboratory use, other than for medical use; data processing apparatus and computers; computer peripherals; downloadable computer programs and software for use in electroporation | ACTIVE | — |
| 010 | Electric and electronic apparatus and instruments for medical use, for electroporation treatment; medical apparatus, and apparatus for pharmaceutical preparations, namely, a pump device connected to an electroporator via a cable system for collecting cells for medical use; electrostimulation apparatus for blood and grafts for therapeutic treatment, for medical or clinical use for the treatment of genetic defects in gene therapy; medical devices, and devices for pharmaceutical preparations, namely, pulse generators and electric fields of the type used in electroporation, namely, electroporators, for transferring chemical or biological molecules into living cells in combatting infectious and viral diseases, cardiovascular diseases and cancer, integration of foreign nucleic acids into the genome of living cells and transient production of proteins or nucleic acids; medical apparatus and instruments designed for electroporation, in particular electroporation apparatus; medical apparatus and instruments for use in electroporation; reaction devices and containers for medical use, namely, electroporation chambers featuring electrodes of metal and conductive polymers for medical use; reaction devices and containers for medical use, namely, electroporation chambers featuring electrodes of metal and conductive polymers for medical use for transferring chemical or biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins or nucleic acids; tubes for medical use for electroporation; metal medical electrodes for medical use; vessels of synthetic materials for medical use, namely, plastic tubings for electroporation; vessels featuring electrodes of metal, for medical use, namely, plastic tubings for electroporation; reaction containers with several reaction chambers, featuring electrodes of metal and conductive polymers, for medical use, namely, plastic tubings for electroporation and electroporation chambers featuring electrodes of metal and conductive polymers for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 10, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 15, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 14, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 13, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 13, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 13, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 29, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 8, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 27, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 22, 2023 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 16, 2023 | ALIE | ASSIGNED TO LIE | — |
| Feb 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 8, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 26, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 26, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 26, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 26, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 26, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 24, 2023 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jan 24, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 24, 2023 | PBSR | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST | — |
| Jan 23, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 23, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 23, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 23, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 23, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 6, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 6, 2022 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Dec 6, 2022 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Dec 6, 2022 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jun 15, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 15, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 15, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 27, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 27, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 23, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 22, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 14, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 2, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |